EVAluation of Erythrocytosis PRospEctive Cohort STudy

NOT YET RECRUITING

NCT06785870

Sponsor: Cyrus Hsia

Summary

The EValuation of ERythrocytosis pRospEctive cohort STudy (EVEREST) is a prospective study designed to shed light on these key questions in the diagnosis, management, and clinical outcomes in patients with elevated hemoglobin (erythrocytosis). This longitudinal, prospective study will generate high quality data that can help inform the optimal approach to diagnosis and management in this patient population.

Official title: Evaluation of Erythrocytosis Prospective Cohort Study (EVEREST): Diagnosis, Management and Longitudinal Outcomes in Patients with Elevated Hemoglobin

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

1500

Start Date

2025-02-01

Completion Date

2030-12-31

Last Updated

2025-01-21

Healthy Volunteers

No

Conditions

Erythrocytosis Polycythemia Polycythemia Secondary Polycythemia Vera Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase Polycythemia Vera (PV)Polycythemia; Familial Polycythemia, Primary

Locations (1)

Victoria Hospital, London Health Sciences Centre

London, Ontario, Canada

Clinical Research Directory